Band 4
Provided by James H. Velema
Intellectual Property
Intellectual Property Diligence
Inter Partes Review
Licensing & Commercial Transactions
Patents
“I take a holistic view of what a clients’ patent portfolio is doing for them to ensure that everything is working and everything has a purpose,” says James Velema. Colleagues call him an “exemplary patent lawyer and strategic advisor who supports clients with a deep understanding of both biotech businesses and their technology.” They say, “His knowledge goes beyond understanding patent law; he is able to leverage that understanding to advance his clients’ business interests, bring products to market, protect their intellectual property, and develop robust patent portfolios.”
Keenly interested in the sciences, clients rely on James to leverage their intellectual property to advance their business interests. The leader of Lathrop GPM’s biotech patent prosecution team, James understands clients’ industries, protects their ideas, examines scientific documents, applies for patent protection, and defends and enforces clients’ patents. He prides himself on providing effective, high-quality and strategic client service while always being responsive.
As a biotech patent attorney, James works with clients from start-ups and emerging biotechnology companies to large academic research institutions and Fortune 500 biotechnology corporations. He combines considerable research experience in industry and academia with a knowledge of intellectual property law to carefully assist clients with patent preparation and prosecution, due diligence, and opinion work.
With a keen understanding of all aspects of a product lifecycle, James supports biotechnology companies with their patent portfolios for:
Antibody technologies
Biologic therapies
Bioprocessing and purification
Cell therapy and immunology
Gene therapy technologies
Oligonucleotide therapeutics including RNAi/siRNA/miRNA
Peptide therapeutics
Protein purification and bioprocesses
Screening assays
Transgenic organisms
Vaccines
He analyzes the patent landscape relating to antibodies including antibody glycobiology, antibody Fc variants, alternative binding scaffolds, fusion proteins, recombinant enzymes, chimeric antigens and discovery platform technologies.
Throughout his career, James has been part of the Boston biotech industry – which now houses the largest biotech hub in the world. A founding partner of the firm’s Boston office, James knows what it is to be an entrepreneur. He takes pride in working with the life sciences companies. James also served as the IP manager and patent agent at a pharmaceutical company, as a research associate at a biotech company, and as an inventor who holds several U.S. patents – all of which equip him with a solid understanding of clients’ needs.
Provided by Chambers
James Velema is the leader of the firm's biotech patent prosecution group. He is adept at handling patent prosecution and IP strategy in the biotech space and represents a variety of clients, from start-ups to large corporations.
Provided by Chambers
James is an exceptional attorney with decades of experience in the IP and pharmaceutical industry.
James is an exceptional attorney with decades of experience in the IP and pharmaceutical industry.